Date

Friday, November 13th 2020 (10:00)

Language

English

Organised by

Johnson & Johnson

Categories

Tags

Partnering with a Venture Capitalist (VC) may fast forward your innovation, because they could bring much more to the table than just funding.

Virtually join JLABS, where Edward van Wezel, Managing Partner BioGeneration Ventures, will elaborate on their aim to build new companies around either single assets or technology platforms with the goal of creating transformational new medicines. Following the presentation, BioGeneration Ventures will meet 1-on-1 with companies, provided they have been accepted after applying online by 28 October.

https://meetbgv.splashthat.com/Partner